In 2017, the Hydroxycarbamide market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.
In United States market, the top players include
Bristol Myers Squibb
Beijing Jialin Pharma
VHB Life Sciences
Split by product types/category, covering
Split by applications/end use industries, covers
Sickle Cell Disease
Have any queries?